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The effective reproduction number, Rt, of Ebola virus 
disease was estimated using country-specific data 
reported from Guinea, Liberia and Sierra Leone to 
the World Health Organization from March to August, 
2014. Rt for the three countries lies consistently above 
1.0 since June 2014. Country-specific Rt for Liberia and 
Sierra Leone have lied between 1.0 and 2.0. Rt<2 indi-
cate that control could be attained by preventing over 
half of the secondary transmissions per primary case. 
Introduction
The largest and first regional outbreak of Ebola virus 
disease (EVD) has been unfolding in West Africa since 
approximately December 2013, with the first cases 
traced back to southern Guinea [1]. However, the out-
break was not recognised until March 2014 [1], which 
facilitated the spread to neighbouring Sierra Leone and 
Liberia through porous borders as well as Nigeria via 
a commercial airplane on 20 July [2]. The World Health 
Organization (WHO) declared this EVD epidemic a 
Public Health Emergency of International Concern on 8 
August 2014 [3]. According to phylogenetic analyses, 
the causative Ebola virus strain is closely related to a 
strain associated with past EVD outbreaks in Central 
Africa, and could have been circulating in West Africa 
for about a decade [4].
A total of 3,707 cases (including 2,106 confirmed, 
1,003 probable and 598 suspected cases, respectively) 
and 1,848 deaths (concerning 1,050 confirmed and 557 
probable cases, as well as 241 suspected cases and 
deaths, respectively) have been reported in Guinea, 
Sierra Leone, Liberia, Nigeria, and Senegal as of 31 
August 2014 [5]. The total number of cases in Guinea, 
Sierra Leone, Liberia, Nigeria and Senegal have been 
771, 1,216, 1,698, 21 and one, respectively. By con-
trast, the great majority of past outbreaks have been 
associated with small numbers of reported cases and 
have been confined to isolated rural areas in Central 
Africa. For reference, the largest outbreaks in Central 
Africa generated 315 cases in Congo in 1976 and 425 
cases in Uganda in 2000 [6,7].
The effective reproduction number, Rt, which measures 
the average number of secondary cases generated by 
a typical primary case at a given calendar time, can be 
helpful to understand the EVD transmission dynam-
ics over time in affected countries as well as gauge 
the effect of control interventions [8]. Values of Rt<1 
indicate that the epidemic is in a downward trend. By 
contrast, an epidemic is in an increasing trend if Rt>1. 
The mean reproduction number for EVD has been esti-
mated at 1.83 for an outbreak in Congo in 1995 and 
1.34 in Uganda in 2000 prior to the implementation of 
control interventions [9]. Here we sought to estimate 
the Rt, in real time in order to assess the current status 
of the evolving outbreak across countries affected in 
2014. We also compare our estimates of the reproduc-
tion number for the current outbreak with those pre-
viously published for the largest outbreaks in Central 
Africa and discuss our findings from a public health 
perspective.
Methods
Case data
We analysed the cumulative case counts reported by 
the WHO [10] as of 26 August 2014. Case counts are 
classified into three categories, i.e. confirmed, prob-
able and suspected cases. Confirmed cases are labo-
ratory diagnosed by polymerase chain reaction (PCR), 
positive IgM antibody or viral isolation while sus-
pected cases correspond to individuals presenting 
fever (≥38.5°C (101°F)) and no favourable response to 
treatment for usual causes of fever in the area, and at 
least one of the following clinical signs: bloody diar-
rhoea, bleeding from gums, bleeding into skin (pur-
pura), bleeding into eyes and urine. Probable cases are 
suspected cases of EVD with an epidemiological link to 
a confirmed EVD case [11]. We analysed two different 
sets of grouped data, i.e. (i) confirmed plus probable 
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cases and (ii) the total number of reported cases (i.e. 
confirmed, probable and suspected cases).
Because case counts were reported in irregular time 
intervals, we estimated daily incidence curves of EVD 
cases in order to estimate Rt. For this purpose, we first 
fit a smoothing spline to country-specific cumulative 
curves of reported cases. Next we took the daily dif-
ference of the cumulative counts to obtain daily inci-
dence time series. Of note, the cumulative case series 
reflects the diagnostic process (among suspected and 
probable cases) and sometimes declined as a function 
of time (e.g. 5 April and 12 July in Guinea and Sierra 
Leone, respectively). When the difference was nega-
tive, we replaced it by 0. The smoothing spline was 
chosen to obtain a coefficient of determination R2 at 
0.995. Data from Nigeria and Senegal have been omit-
ted due to a limited number of cases recorded in these 
countries thus far.
Mathematical model
We employed mathematical modelling together with 
time- and country-specific incidence data to estimate 
the Rt. Thus, here we model the transmission dynamics 
of EVD using a country-specific next-generation matrix 
{kij,t} representing the average number of secondary 
cases in country i at time t generated by a single pri-
mary case in country j. Let gt represent the probability 
density function of the generation time of length t days 
for EVD. Hence, the expected value of EVD incidence in 
country i at time t is modelled as 
The univariate version of Equation 1 has been employed 
by White and Pagano [12,13] in order to jointly esti-
mate R0 and the generation time distribution of EVD. 
Assuming that EVD incidence follows a Poisson distri-
bution, the likelihood to estimate {kij,t} is
where ri,t is the estimated daily incidence in country i 
on day t derived from the difference of the smoothing 
spline fit to the cumulative data as explained above.
Each element of the next-generation matrix is inter-
preted as the average number of secondary cases gen-
erated by a single primary case at time t. We assume 
that the per-contact probability of infection and the 
average generation time do not differ by country. Thus, 
the contact matrix regulates the relative difference 
between each pair of entries of the next-generation 
matrix, and because the contact patterns within and 
between countries cannot be directly observed, we 
made a qualitative assumption for the matrix {kij,t} to 
approximately capture the pattern of (domestic and 
transnational) transmission [14], i.e.
The matrix Mt qualitatively assumes that there are 
more frequent within-country transmissions (denoted 
by kg,t, ks,t and kl,t, where the subscripts g, s and l rep-
resent Guinea, Sierra Leone and Liberia, respectively) 
compared with transnational spread. The transna-
tional spread is modelled by a single parameter α. We 
employed a piecewise constant model and change the 
parameters for the above-mentioned elements every 
seven days. Maximum likelihood estimates of the 
parameters were obtained by minimising the negative 
logarithm of Equation 2. Using the most recent inci-
dence estimate i0 and the exponential growth rate r as 
calculated from r=(R-1)/12 (where R is the most recent 
reproduction number and 12 is the mean generation 
time), the expected number of additional cases in 2014 
was calculated as 
. The expected cases represent a ‘worst-case’ scenario 
based on the current situation by assuming a fixed 
reproduction number R for the remainder of the year 
(i.e. approximately 120 days remaining in 2014).
We also computed the Rt for all countries (hereafter 
referred to as the ‘global’ estimate of the reproduction 
number) by calculating the dominant eigenvalue of the 
estimated next-generation matrices. Moreover, we cal-
culated column sums of the matrices to estimate the 
average number of secondary transmissions arising 
in and from a specific country and also extracted esti-
mates of 2α, the value that governs the transnational 
spread generated by a single primary case. Although 
White and Pagano achieved the joint estimation of R0 
and generation time distribution [12,13], we assumed 
that the generation time is known, because our analy-
sis relies solely on the cumulative number of reported 
cases with irregular reporting intervals. The genera-
tion time was assumed to follow an exponential distri-
bution with a mean of 12 days [15], which is known to 
be close to the mean incubation period [16]. Based on 
empirical data of the serial interval distribution [15], we 
also carried out a sensitivity analysis of reproduction 
numbers by varying the mean generation time between 
nine and 15 days. The 95% confidence intervals of the Rt 
can be computed via bootstrapping methods. However, 
our study focused on examining model uncertainty 
associated with the transnational mixing patterns and 
the mean generation time as model uncertainty in 
our study is likely more influential on Rt compared to 
uncertainty relating to measurement error. In sensitiv-
ity analyses, we also examined the impact of varying 
specified time interval on Rt. For this purpose, we also 
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analysed the piecewise constant model for every six 
and eight days instead of seven days.
Results
Figure 1 illustrates the process of deriving daily EVD 
incidence curves by country from cumulative curves of 
reported cases. Multiple fluctuations are evident from 
the incidence curve for Guinea (Figure 1). In Liberia, 
the early transmission phase did not appear to exhibit 
sustained growth and was probably driven by case 
importations during first epidemic month. Exponential 
growth was subsequently seen, reflecting self-sus-
taining transmission. Similarly, the incidence curve for 
Sierra Leone also displayed steady growth since early 
June. Most recent EVD incidence data for Guinea also 
showed an increasing pattern.
Our weekly maximum likelihood estimates of the Rt 
for each affected country and for the global system in 
West Africa are displayed in Figure 2. Results indicate 
that the reproduction number for all countries reached 
levels below unity in April and May, but has appeared 
to be continuously above one since early June (Figure 
2A). This pattern was robust when using two different 
datasets (including and excluding suspected cases). 
Estimates of Rt using total case reports from June to 
July 2014, a period during which exponential growth of 
cases has been observed in Sierra Leone and Liberia, 
ranged from 1.4 to 1.7, respectively. In the hypothetical 
worst-case scenario that the current situation with an 
estimated reproduction number R ranging from 1.4 to 
1.7 continues for the remainder of the year, we would 
expect to observe a total of 77,181 to 277,124 additional 
cases within 2014.
Maximum likelihood estimates of Rt in Guinea appeared 
to have fluctuated around 1.0 (Figure 2B), which reflects 
the observed variation in the corresponding incidence 
curve. Importantly, Rt in this country has not been 
continuously below 1.0, which supports the view that 
in this country the outbreak is not yet under control. 
Estimates of Rt in Sierra Leone and Liberia appeared to 
be consistently above 1.0 up to week 22 (i.e. the week 
starting on 18 August) (Figure 2C and 2D). Although Rt 
in Sierra Leone has been declining with the highest 
estimates obtained for early June, Rt has not been con-
sistently below 1.0 in this country, including estimates 
for the latest reporting week (Figure 2). The pattern 
of Rt in Liberia shows values well above 1.0 since July 
2014. In this country, the estimates of Rt reaching val-
ues up to 2.0 indicate that the outbreak could only be 
brought under control if more than half of secondary 
transmissions per primary case were prevented.
Figure 3A shows the estimated average number of 
transnational transmissions per single primary case 
as a function of time (calculated by 2α). α has been 
high in early June, but has declined dramatically since 
late June. Nevertheless, most recent model estimates 
still suggest a non-negligible number of cross-border 
Figure 1
Cumulative and daily epidemic curves of Ebola virus disease (EVD) in Guinea, Liberia, and Sierra Leone,  
23 March–26 August 2014
A)Cumulative number of confirmed or probable cases of EVD reported to the World Health Organization [10]. Solid lines are the smoothing 
spline fits to cumulative curves for each country with a coefficient of variation R2 at 0.995. 
B) Estimated daily incidence curves based on the smoothing spline model. Data from Nigeria and Senegal have been omitted due to the 
limited number of cases recorded in these countries thus far.
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transmissions. Figure 3B examines the sensitivity of 
Rt for all countries to changes in the mean generation 
time. Although the absolute values of Rt are positively 
correlated with the mean generation time, the above-
mentioned qualitative patterns of Rt are preserved, 
which indicates that the ongoing EVD epidemic has 
yet to be brought under control. Figure 3C examines 
the sensitivity of Rt to a specified time interval of 
the piecewise constant model. Perhaps not surpris-
ingly, as the interval is shortened, fluctuations in Rt 
tend to increase, perhaps due to stochastic effects. 
Nevertheless, all models roughly provide qualitatively 
similar patterns in Rt.
Discussion
We have derived global and country-specific esti-
mates of the Rt of EVD for the ongoing outbreak in 
West Africa. Our global estimates of the Rt appear to 
be continuously above one since early June, indicat-
ing that the epidemic has been steadily growing and 
has not been brought under control as of 26 August 
2014. The country-specific estimates for Sierra Leone 
and Liberia were also above one, perhaps reflecting 
the increasing trend in cases in these countries since 
June. Our estimated reproduction numbers, broadly 
ranging from one to two, are consistent with published 
estimates from prior outbreaks in Central Africa [9,17]. 
Our estimates of Rt<2 indicate that the outbreak could 
Figure 2
Effective reproduction number of Ebola virus disease (EVD) estimated for Guinea, Sierra Leone, Liberia, and for the global 
system in West Africa, 23 March–26 August 2014
A) Global (maximum likelihood) estimates of the effective reproduction number of EVD based on data from all affected countries (Guinea, 
Sierra Leone and Liberia) were derived from the dominant eigenvalue of the next generation matrix. 
B-D) The average number of secondary transmissions arising from Guinea, Sierra Leone and Liberia, was calculated from the corresponding 
column sum of the next generation matrix. The horizontal grey solid line indicates the reproduction number at 1.0 for reference, below 
which the epidemic follows a declining trend. Estimates were derived using either confirmed cases plus probable cases or the total reported 
case counts (confirmed, probable plus suspected cases). Data from Nigeria and Senegal have been omitted due to limited number of cases 
recorded thus far. Epidemic week 0 corresponds to the week that includes 22 March 2014.
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be brought under control if more than half of secondary 
transmissions per primary case are prevented.
Our statistical analysis of the reproduction number of 
EVD in West Africa has demonstrated that the continu-
ous growth of cases from June to August 2014 signalled 
a major epidemic, which is in line with estimates of the 
Rt above 1.0. Moreover, the timing of Rt reaching levels 
above one is in line with a concomitant surge in cases 
in Sierra Leone and Liberia. In a worst-case hypotheti-
cal scenario, should the outbreak continue with recent 
trends, the case burden could gain an additional 77,181 
to 277,124 cases by the end of 2014. Although such 
numbers must be interpreted with caution (as they rest 
on an assumption of continued exponential growth 
within 2014, which is unlikely), our study supports the 
notion that the ongoing EVD epidemic must be regarded 
as a Public Health Emergency of International Concern 
[3]. This finding also implies that transnational spread 
of EVD might have hindered control efforts, suggesting 
that preparedness plans for potential case introduc-
tions is critical particularly for countries at high risk 
of EVD case importations [18] with suboptimal public 
health systems. The transnational spread per person 
appears to have been reduced over time, but our most 
recent model estimates still suggest a non-negligible 
number of secondary cases arising from transnational 
spread. Uncontrolled cross-border transmission could 
fuel a major epidemic to take off in new geographical 
areas (e.g. as seen in Liberia). Unaffected countries at 
risk of transnational spread should be on high alert 
for potential EVD introductions and be ready to launch 
comprehensive and timely containment responses to 
avert outbreaks.
Our analysis is not exempted of limitations. First, the 
epidemic is ongoing in multiple geographical locations, 
and no simple mixing matrix can capture the complex 
geographical patterns of spread in the region. Second, 
cases may be under-ascertained, and hence reported 
cases may represent only a portion of the total num-
ber of infected individuals. However, our estimates of 
the reproduction number are not affected whenever 
the diagnosis and reporting rates have not dramati-
cally changed over time. Third, the reporting delays 
are known to induce a downward bias in incidence in 
the latest observation, which can complicate real-time 
analyses. Several studies have successfully addressed 
this bias [19-22], but we were unable to incorporate 
this delay into our analyses due to a lack of empirical 
data to characterise the reporting delay distribution.
Despite the above-mentioned limitations, we believe 
that our findings are useful to demonstrate that the 
cases have been steadily growing in the last three 
months with an Rt above one. Close monitoring of this 
evolving epidemic should continue in order to assess 
the status of the outbreak in real time and guide con-
trol interventions in the region. Reviewing possible 
countermeasures for countries at risk of transnational 
Figure 3
Sensitivity analysis of the effective reproduction number 
of Ebola virus disease (EVD), West Africa, 23 March–26 
August 2014
A) The estimated average number of secondary cases per single 
primary case arising from transnational spread. Solid lines 
represents estimates derived from the mean generation time 
of 12 days, while dashed lines correspond to estimates derived 
using nine and 15 days as the mean generation time. 
B) Upper and lower bounds of the effective reproduction number 
(Rt)for the global dynamics in West Africa are shown assuming a 
mean generation time of EVD ranging from nine to 15 days. The 
horizontal grey line is shown as a reference for the reproduction 
number at 1.0 below which the epidemic follows a declining 
trend. 
C) Sensitivity of Rt to varying specified time intervals of the 
piecewise constant model. Estimates in B and C were derived 
using the total number of reported EVD cases (confirmed, 
probable plus suspected cases). Epidemic week 0 corresponds 
to 22 March 2014. Of note, estimates overlap at week 9 as these 
were derived from epidemiological data for a single country (i.e. 
Guinea). 
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spread [18] would be of utmost importance to confront 
the ongoing propagation of cases over time and space. 
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